Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes von de Swart, Louise, Reiniers, Chloé, Bagguley, Timothy, van Marrewijk, Corine, Bowen, David, Hellström-Lindberg, Eva, Tatic, Aurelia, Symeonidis, Argiris, Huls, Gerwin, Cermak, Jaroslav, van de Loosdrecht, Arjan A, Garelius, Hege, Culligan, Dominic, Macheta, Mac, Spanoudakis, Michail, Panagiotidis, Panagiotis, Krejci, Marta, Blijlevens, Nicole, Langemeijer, Saskia, Droste, Jackie, Swinkels, Dorine W, Smith, Alex, de Witte, Theo

Volltext

Labile Plasma Iron (LPI) Is a Clinical Indicator of Overt Iron Overload in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS Registry von De Swart, Louise, Reiniers, Chloé, Bagguley, Tim, Bowen, David, Cermak, Jaroslav, Hellström-Lindberg, Eva, Tatic, Aurelia, Symeonidis, Argiris, Huls, Gerwin, Panagiotidis, Panagiotis, Garelius, Hege, Culligan, Dominic, Krejci, Marta, van Marrewijk, Corine, Droste, Jackie, Smith, Alexandra, Swinkels, Dorine W., de Witte, Theo

Volltext

Hepcidin and GDF15 Levels during the First 2 Years Follow-up in Patients with Low and Int-1 Risk Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS Registry von De Swart, Louise, Reiniers, Chloé, Bagguley, Tim, van Marrewijk, Corine, Bowen, David, Cermak, Jaroslav, Hellström-Lindberg, Eva, Tatic, Aurelia, Symeonidis, Argiris, Huls, Gerwin A, Smith, Alex, de Witte, Theo

Volltext

Labile plasma iron levels predict survival in patients with lower-risk Myelodysplastic syndromes von de Swart, Louise, Reiniers, Chloé, Bagguley, Timothy, van Marrewijk, Corine, Bowen, David, Hellström-Lindberg, Eva, Tatic, Aurelia, Symeonidis, Argiris, Huls, Gerwin, Cermak, Jaroslav, van de Loosdrecht, Arjan A, Garelius, Hege, Culligan, Dominic, Macheta, Mac, Spanoudakis, Michail, Panagiotidis, Panagiotis, Krejci, Marta, Blijlevens, Nicole, Langemeijer, Saskia, Droste, Jacqueline, Swinkels, Dorine W, Smith, Alexandra, de Witte, Theo

Volltext bestellen